Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 12Neoplasms 4Neoplasm Metastasis 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms by Site 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Low Grade Serous Ovarian Carcinoma 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Liposarcoma 1Leiomyosarcoma 1Hereditary Sensory and Autonomic Neuropathies 1Hemangiosarcoma 1HR+/HER2- Breast Cancer 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 14Temozolomide 11Specimen Handling 10X-Rays 7Biopsy 7Nuclear Medicine Department, Hospital 6Phantoms, Imaging 5erdafitinib 4Radiation 4ulixertinib 3trametinib 3larotrectinib 3dabrafenib 3Radiotherapy 3tipifarnib 2selpercatinib 2palbociclib 2ivosidenib 2ensartinib 2binimetinib 2Surgical Procedures, Operative 2Nivolumab 2veliparib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1temsirolimus 1tazemetostat 1selinexor 1sapanisertib 1ribociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × abemaciclib × 30 days × Clear all
NCT06413706 2026-05-22

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Eli Lilly and Company

Phase 2 Active not recruiting
45 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡